Detection of metallo-β-lactamase in imipenem-resistant Pseudomonas aeruginosa

ISSN: 10018689
0Citations
Citations of this article
30Readers
Mendeley users who have this article in their library.

Abstract

Carbapenems are the primary choice of treatment for severe Pseudomonas aeruginosa infection. However, the emergence of carbapenem resistance due to the production of metallo- β -lactamases (MBLs) is of global concern. In this study, 90 imipenem- (IPM- or IP-) resistant P. aeruginosa (IRPA) isolates, including 32 previously tested positive and genotyped for MBL genes by PCR, were subjected to double-disk synergy test (DDST), combined disk test (CDT), and imipenem/imipenem-inhibitor (IP/IPI) E -test to evaluate their MBLs detection capability. All three methods were shown to have a sensitivity of 100%. However, DDST was the most specific of the three (96.6%), followed by IP/IPI E -test interpreted based on the single criteria of IP/IPI ≥8 as positive (62.1%), and CDT was the least specific (43.1%). Based on the data from this evaluation, we propose that only IRPA with IP MIC >16 μ g/mL and IP/IPI ≥8 by IP/IPI E -test should be taken as positive for MBL activity. With the new dual interpretation criteria, the MBL IP/IPI E -test was shown to achieve 100% sensitivity as well as specificity for the IRPA in this study. Therefore, the IP/IPI E -test is a viable alternative phenotypic assay to detect MBL production in IRPA in our population in circumstances where PCR detection is not a feasible option.

Cite

CITATION STYLE

APA

Yu, G. chao, Xu, L., Yuan, G. qing, Zhang, T., Chen, K., Jiang, G., … Cao, K. yuan. (2011). Detection of metallo-β-lactamase in imipenem-resistant Pseudomonas aeruginosa. Chinese Journal of Antibiotics, 36(3), 223–227.

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free